C

CorMedix
D

CRMD

14.830
USD
0.47
(3.27%)
مغلق
حجم التداول
87,530
الربح لكل سهم
1
العائد الربحي
-
P/E
19
حجم السوق
1,107,044,551
الأفكار والتحليلات
هشام منسي
هشام منسي
منذ 10 أشهر
buy
2024-10-03 07:52
CRMD Chart
المزيد
أصول ذات صلة
A
AGEN
-0.07000
(-1.65%)
4.18000 USD
A
AKBA
0.02000
(0.64%)
3.14500 USD
C
CLRB
0.28000
(5.97%)
4.97000 USD
D
DVAX
-0.155
(-1.51%)
10.120 USD
M
MDGL
1.46
(0.33%)
438.05 USD
R
RDHL
-0.06000
(-4.41%)
1.30000 USD
R
RMTI
-0.10500
(-5.80%)
1.70500 USD
S
SNDX
0.015
(0.09%)
16.330 USD
المزيد
الأخبار المقالات

العنوان: CorMedix

القطاع: Healthcare
الصناعة: Biotechnology
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.